Kazanılmış Epilepsiler

Agrawal A, Timothy J, Pandit L, Manju M. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg. 200; 108(5): 433–9.

Bruns TJ, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia. 2003; 44:2–10.

Salazar AM, Grafman J. Posttraumatic epilepsy: clinical clues to pathogenesis and paths to prevention. Handb Clin Neurol. 2015; 128: 525–38.

Jennett B. Epilepsy After Blunt Head Injuries. London, UK: William Heinemann Medical Books Ltd, 1962.

Ritter AC, Wagner AK, Fabio A, et al. Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a Traumatic Brain Injury Model Systems Study. Epilepsia. 2016;57(12):1968-77.

Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology. 1980; 30: 683–9.

Christensen J. The epidemiology of posttraumatic epilepsy. Sem Neurol. 2015; 35: 218–22.

Hahn YS, Fuchs S, Flannery AM, Barthel MJ, McLone DG. Factors influencing posttraumatic seizures in children. Neurosurgery. 1988; 22: 864–7.

Pechadre J, lauxerois M, Colnet G, Dimicoli C, Bonnard M, Gibert J, et al. Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries. 2 years' follow-up. Presse medicale. 1991;20(18):841-5.

Laing J, Gabbe B, Chen Z, Perucca P, Kwan P, O’Brien TJ. Risk Factors and Prognosis of Early Posttraumatic Seizures in Moderate to Severe Traumatic Brain Injury. JAMA Neurol. 2022;79(4):334–341.

Barlow KM, Thomson E, Johnson D, Minns RA. Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy. Pediatrics. 2005;116(2):174-85.

Blumcke I, Spreafico R, Haaker G, et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. N Engl J Med. 2017; 377(17):1648–1656.

Blumcke I, Aronica E, Becker A, et al. Low-grade epilepsy-associated neuroepithelial tumours – the 2016 WHO classification. Nat Rev Neurol 2016; 12:732–40.

Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: Section V: Symptomatic Epilepsies of Acquired Origin a practical clinical definition of epilepsy. Epilepsia. 2014; 55:475–82

Wells EM, Gaillard WD, Packer RJ. Pediatric brain tumors and epilepsy. Semin Pediatr Neurol. 2012;19(1):3-8.

Rossetti AoStupp R. Epilepsy in brain tumor patients. Curr opin Neurol. 2010;23(6):603- 9.

Crino PB. Focal Cortical Dysplasia. Semin Neurol. 2015;35(3):201-208.

Ruggiero A, Rizzo D, Mastrangelo S, Battaglia D, Attina G, Riccardi R. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment?. Pediatr Blood Cancer. 2010;54 (2):193-8.

Khan RB, onar A. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia. 2006;47(2):375-9.

Stahl JP, Mailles A, Dacheux L, et al. Epidemiology of viral encephalitis in 2011. Med Mal Infect. 2011; 41:453–464.

Misra UK, Kalita J. Seizures in encephalitis: Predictors and outcome. Seizure 2009; 18:583–587.

Bale JF, Jr. Virus and immune-mediated encephalitides: Epidemiology, diagnosis, treatment, and prevention. Pediatr Neurol. 2015; 53:3–12.

Malani Shukla N, Lotze TE, Muscal E. Inflammatory Diseases of the Central Nervous System. Neurol Clin. 2021;39(3):811-828.

Poyrazoğlu HG, Kırık S, Sarı MY, Esen İ, Toraman ZA, Eroğlu Y. Acute demyelinating encephalomyelitis and transverse myelitis in a child with COVID-19. Turk J Pediatr. 2022;64(1):133-137.

Bulakbasi N, Kocaoglu M. Central nervous system infections of herpesvirus family. Neuroimaging Clin N Am. 2008;18:53–84; viii.

Jafarpour S, Santoro JD. Autoimmune Encephalitis. Pediatr Rev. 2022;43(4):198-211.

Nosadini M, Thomas T, Eyre M, et al. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021;8(5):e1052.

Quade A, Rostasy K, Wickström R, et al. Autoimmune Encephalitis with Autoantibodies to NMDAR1 following Herpes Encephalitis in Children and Adolescents. Neuropediatrics. 2023;54(1):14-19.

Burneo JG, Fang J, Saposnik G, et al. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-center cohort study. Eur J Neurol. 2010; 17(1):52–8

AHA/ASA Expert Consensus Document. An Updated Definition of Stroke for the 21st Century. A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2013; 44:2064–89.

Prengler M, Pavlakis SG, Boyd S, et al. Sickle cell disease: ischemia and seizures. Ann Neurol. 2005; 58:290–302.

Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004; 114:e206–12.

Matta AP, Galväo KR, Oliveira BS. Cerebrovascular disorders in childhood: etiology, clinical presentation, and neuroimaging findings in a case series study. Arq Neuropsiquiatr. 2006; 64(2A): 181–5.

Billinghurst LL, Beslow LA, Abend NS, et al. Incidence and predictors of epilepsy after pediatric arterial ischemic stroke. Neurology 2017; 88(7):630–7.

López-Espejo M, Hernández-Chávez M, Huete I. Clinical and radiological risk factors for poststroke epilepsy in childhood. Epilepsy Behav. 2018;88:113-16.

Sundelin HEK, Tomson T, Zelano J, Söderling J, Bang P, Ludvigsson JF. Pediatric Ischemic Stroke and Epilepsy: A Nationwide Cohort Study. Stroke. 2021;52(11):3532-40.

Fox CK, Glass HC, Sidney S, lowenstein DH, Fullerton HJ. Acute seizures predict epilepsy after childhood stroke. Annals of neurology. 2013;74(2):249-56.

Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, lampl Y. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clinical neuropharmacology. 2007;30(4):189-95.

Consoli D, Bosco D, Postorino P, et al. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). Cerebrovascular diseases. 2012;34(4):282- 9.

Na M, Ge H, Shi C, Shen H, Wang Y, Pu S ve ark. Long-term seizure outcome for international consensus classification of hippocampal sclerosis: a survival analysis. Seizure 2015;25:141-6.

Hesdorffer DC, Shinnar S, Lewis DV, et al. Design and phenomenology of the FEBSTAT study. Epilepsia 2012;53:1471-80.

Kwan P, Brodie MJ. Drug treatment of epilepsy: when does it fail and how to optimize its use? CNS Spectr. 2004; 9: 110–119.

Yoon HH, Kwon HL, Mattson RH, Spencer DD, Spencer SS. Longterm seizure outcome in patients initially seizure-free after resective epilepsy surgery. Neurology. 2003; 61: 445–450.

Agrawal A, Timothy J, Pandit L, Manju M. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg. 200; 108(5): 433–9.

Bruns TJ, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia. 2003; 44:2–10.

Salazar AM, Grafman J. Posttraumatic epilepsy: clinical clues to pathogenesis and paths to prevention. Handb Clin Neurol. 2015; 128: 525–38.

Jennett B. Epilepsy After Blunt Head Injuries. London, UK: William Heinemann Medical Books Ltd, 1962.

Ritter AC, Wagner AK, Fabio A, et al. Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a Traumatic Brain Injury Model Systems Study. Epilepsia. 2016;57(12):1968-77.

Annegers JF, Grabow JD, Groover RV, et al. Seizures after head trauma: a population study. Neurology. 1980; 30: 683–9.

Christensen J. The epidemiology of posttraumatic epilepsy. Sem Neurol. 2015; 35: 218–22.

Hahn YS, Fuchs S, Flannery AM, Barthel MJ, McLone DG. Factors influencing posttraumatic seizures in children. Neurosurgery. 1988; 22: 864–7.

Pechadre J, lauxerois M, Colnet G, Dimicoli C, Bonnard M, Gibert J, et al. Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries. 2 years' follow-up. Presse medicale. 1991;20(18):841-5.

Laing J, Gabbe B, Chen Z, Perucca P, Kwan P, O’Brien TJ. Risk Factors and Prognosis of Early Posttraumatic Seizures in Moderate to Severe Traumatic Brain Injury. JAMA Neurol. 2022;79(4):334–341.

Barlow KM, Thomson E, Johnson D, Minns RA. Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy. Pediatrics. 2005;116(2):174-85.

Blumcke I, Spreafico R, Haaker G, et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. N Engl J Med. 2017; 377(17):1648–1656.

Blumcke I, Aronica E, Becker A, et al. Low-grade epilepsy-associated neuroepithelial tumours – the 2016 WHO classification. Nat Rev Neurol 2016; 12:732–40.

Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: Section V: Symptomatic Epilepsies of Acquired Origin a practical clinical definition of epilepsy. Epilepsia. 2014; 55:475–82

Wells EM, Gaillard WD, Packer RJ. Pediatric brain tumors and epilepsy. Semin Pediatr Neurol. 2012;19(1):3-8.

Rossetti AoStupp R. Epilepsy in brain tumor patients. Curr opin Neurol. 2010;23(6):603- 9.

Crino PB. Focal Cortical Dysplasia. Semin Neurol. 2015;35(3):201-208.

Ruggiero A, Rizzo D, Mastrangelo S, Battaglia D, Attina G, Riccardi R. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment?. Pediatr Blood Cancer. 2010;54 (2):193-8.

Khan RB, onar A. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia. 2006;47(2):375-9.

Stahl JP, Mailles A, Dacheux L, et al. Epidemiology of viral encephalitis in 2011. Med Mal Infect. 2011; 41:453–464.

Misra UK, Kalita J. Seizures in encephalitis: Predictors and outcome. Seizure 2009; 18:583–587.

Bale JF, Jr. Virus and immune-mediated encephalitides: Epidemiology, diagnosis, treatment, and prevention. Pediatr Neurol. 2015; 53:3–12.

Malani Shukla N, Lotze TE, Muscal E. Inflammatory Diseases of the Central Nervous System. Neurol Clin. 2021;39(3):811-828.

Poyrazoğlu HG, Kırık S, Sarı MY, Esen İ, Toraman ZA, Eroğlu Y. Acute demyelinating encephalomyelitis and transverse myelitis in a child with COVID-19. Turk J Pediatr. 2022;64(1):133-137.

Bulakbasi N, Kocaoglu M. Central nervous system infections of herpesvirus family. Neuroimaging Clin N Am. 2008;18:53–84; viii.

Jafarpour S, Santoro JD. Autoimmune Encephalitis. Pediatr Rev. 2022;43(4):198-211.

Nosadini M, Thomas T, Eyre M, et al. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021;8(5):e1052.

Quade A, Rostasy K, Wickström R, et al. Autoimmune Encephalitis with Autoantibodies to NMDAR1 following Herpes Encephalitis in Children and Adolescents. Neuropediatrics. 2023;54(1):14-19.

Burneo JG, Fang J, Saposnik G, et al. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-center cohort study. Eur J Neurol. 2010; 17(1):52–8

AHA/ASA Expert Consensus Document. An Updated Definition of Stroke for the 21st Century. A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2013; 44:2064–89.

Prengler M, Pavlakis SG, Boyd S, et al. Sickle cell disease: ischemia and seizures. Ann Neurol. 2005; 58:290–302.

Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004; 114:e206–12.

Matta AP, Galväo KR, Oliveira BS. Cerebrovascular disorders in childhood: etiology, clinical presentation, and neuroimaging findings in a case series study. Arq Neuropsiquiatr. 2006; 64(2A): 181–5.

Billinghurst LL, Beslow LA, Abend NS, et al. Incidence and predictors of epilepsy after pediatric arterial ischemic stroke. Neurology 2017; 88(7):630–7.

López-Espejo M, Hernández-Chávez M, Huete I. Clinical and radiological risk factors for poststroke epilepsy in childhood. Epilepsy Behav. 2018;88:113-16.

Sundelin HEK, Tomson T, Zelano J, Söderling J, Bang P, Ludvigsson JF. Pediatric Ischemic Stroke and Epilepsy: A Nationwide Cohort Study. Stroke. 2021;52(11):3532-40.

Fox CK, Glass HC, Sidney S, lowenstein DH, Fullerton HJ. Acute seizures predict epilepsy after childhood stroke. Annals of neurology. 2013;74(2):249-56.

Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, lampl Y. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clinical neuropharmacology. 2007;30(4):189-95.

Consoli D, Bosco D, Postorino P, et al. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). Cerebrovascular diseases. 2012;34(4):282- 9.

Na M, Ge H, Shi C, Shen H, Wang Y, Pu S ve ark. Long-term seizure outcome for international consensus classification of hippocampal sclerosis: a survival analysis. Seizure 2015;25:141-6.

Hesdorffer DC, Shinnar S, Lewis DV, et al. Design and phenomenology of the FEBSTAT study. Epilepsia 2012;53:1471-80.

Kwan P, Brodie MJ. Drug treatment of epilepsy: when does it fail and how to optimize its use? CNS Spectr. 2004; 9: 110–119.

Yoon HH, Kwon HL, Mattson RH, Spencer DD, Spencer SS. Longterm seizure outcome in patients initially seizure-free after resective epilepsy surgery. Neurology. 2003; 61: 445–450.